ARCHIVES

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NY Attorney General Sues Drug Companies Over Cancer Drug Pricing Deals

February 14, 2003

NSABP Donates Sculpture to NIH to Commemorate 50th Year.

September 19, 2008

Waxman Hearing Turns Out Strong Support For Cancer Program Renewal

February 29, 1980

Low Prevalence Of Tamoxifen Use For Cancer Prevention

February 26, 2010

Exit Joseph Nevins: Duke’s Genomics Luminary Quietly Leaves

October 18, 2013

AACR Supports Bypass Budget; Public Consortium Sequences Mouse Genome

May 10, 2002